Physician profile
James Michael Mcqueen
NPI 1740268259
$2,068.20
in general payments reported to CMS, 2019-2025
17 companies · $233 in 2025
The $233 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $185 · 2020: $218 · 2021: $440 · 2022: $208 · 2023: $505 · 2024: $279 · 2025: $233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $831 · Education: $186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $831.12 |
| Education | $185.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $640.61 | 2020-2025 | |
| Regeneron Healthcare Solutions, INC. | $449.17 | 2020-2025 | Dupixent |
| Optinose US, INC. | $360.23 | 2019-2024 | |
| Sanofi-Aventis U.S. LLC | $151.98 | 2023-2024 | |
| Janssen Pharmaceuticals, INC | $56.69 | 2020 | |
| Intersect Ent, INC. | $56.24 | 2019 | |
| Pfizer INC. | $54.30 | 2023 | |
| Merck Sharp & Dohme LLC | $46.30 | 2021-2023 | |
| Genentech USA, INC. | $42.26 | 2022-2024 | Xolair |
| Corcept Therapeutics | $42.21 | 2020 | |
| Amgen INC. | $34.00 | 2025 | |
| Kaleo, INC. | $33.67 | 2020-2021 | |
| Aerin Medical INC. | $25.79 | 2020 | |
| Paratek Pharmaceuticals, INC. | $22.56 | 2025 | Xhance |
| Glaxosmithkline, LLC. | $19.24 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $17.71 | 2025 | Rexulti |
| E.R. Squibb & Sons, L.L.C. | $15.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Mcqueen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.